Non‐ <scp>RASopathy</scp> Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome

Noonan Syndrome (NS) is a clinically and genetically heterogeneous condition characterized by typical facial dysmorphisms, short stature, congenital heart defects, and developmental delays. While variants in genes such as PTPN11, SOS1, and RAF1 account for most genetically confirmed cases, diagnosis is challenging due to phenotypic overlap with other syndromes. In this retrospective study, we reviewed 192 patients with a clinical diagnosis of NS at a single tertiary center. Genetic diagnosis of NS was confirmed in 133 patients (69.4%) and diagnosis of non-NS RASopathies was confirmed in 5 patients via targeted RASopathy panels. Exome sequencing (ES) was performed in 20 of the undiagnosed patients. In six cases, alternative genetic diagnoses were established due to variants in SETD5, BRPF1, DPH1, ACTB, CREBBP, and GATA4, genes associated with syndromes presenting overlapping phenotypes with NS. Our findings emphasize the utility of a hypothesis-free approach that uses phenotypic features to prioritize variants in resolving diagnostic uncertainty in NS-like presentations. These findings also highlight the need to broaden differential diagnoses beyond RASopathies when genetic confirmation of NS cannot be established.